Neurogenic Bladder/Underactive Bladder

  • Michelle J. LajinessEmail author



  1. 1.

    Discuss the definition and incidence of underactive bladder (UAB).

  2. 2.

    Describe assessment techniques in UAB.

  3. 3.

    Discuss appropriate interventions for the treatment of UAB.



Botulinum Toxin Pelvic Organ Prolapse Lower Urinary Tract Symptom Lower Urinary Tract Pelvic Floor Muscle Training 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abrams P, Cardozo L, Fall M, Griffiths D et al. Standardisation Sub-committee of the International Continence Society (2002) The standardization of terminology of lower urinary tract function: report from the Standardisation Sub- committee of the International Continence Society. Neurol Urodyn 21(2):167–178Google Scholar
  2. AHFS Drug Information (2009) BOTOX®. Retrieved 2 Sep 2009. From
  3. American Urological Association. White paper on catheter-associated urinary tract infections: definitions and significance in the urologic patient 2014. Downloaded from On 29 June 2015
  4. Barendrecht MM, Oelke M, Laguna MP, Micheal MC (2007) Is the use of parasympathomimetics for treating an underactive bladder evidence based? BJU Int 99:749–752CrossRefPubMedGoogle Scholar
  5. Chancellor M (2009) Ten years single surgeon experience with botulinum toxin in the urinary tract: clinical observations and research discovery. Int Urol Nephrol J 42(2):383–391Google Scholar
  6. Chancellor M (2014) The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol 46(Suppl 1):523–527Google Scholar
  7. Chancellor M, Diokno AC (2014) CURE-UAB shedding light on the underactive bladder syndrome. Int Urol Neph 46(Suppl 1):S1CrossRefGoogle Scholar
  8. Diokno A (2015) Evaluation and diagnosis of underactive bladder in The Underactive Bladder. In: Chancellor M: Diokino A (eds) pp 13–24Google Scholar
  9. Diokno AC, Brock BM, Brown MB, Herzog AR (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136:1022–1025PubMedGoogle Scholar
  10. Griebling T (2015) Geriatric Urology and Underactive Bladder in The Underactive Bladder. In: Chancellor M; Diokno A (eds) Springer Switzerland pp 177–188Google Scholar
  11. Jamison J, Maquire S, Mcann J (2013) Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders (Review). Cochrane Libr 11:1–59Google Scholar
  12. Lapides J, Diokno A, Silber S, Lowe B (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107(3):458–4613PubMedGoogle Scholar
  13. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS (2006) Comparison of pelvic floor muscle training, electromyography biofeedback and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn 25:337–348CrossRefPubMedGoogle Scholar
  14. McClurg D, Ashe RG, Lowe-Strong AS (2008) Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis-a double blind, placebo controlled, randomised clinical trial. Neurourol Urodyn 27:231–237CrossRefPubMedGoogle Scholar
  15. Miyazato M, Yoshimura N, Chancellor M (2013) The other bladder syndrome: underactive bladder. Rev Urol 15(1):11–22PubMedPubMedCentralGoogle Scholar
  16. Newman D, Wein A (2009) Managing and treating urinary incontinence, 2nd edn. Health Professions Press, Baltimore, pp 365–483Google Scholar
  17. Newman D, Wilson M (2011) Review of intermittent catheterization and current best practices. Urol Nurs 31(1):12–28PubMedGoogle Scholar
  18. Osman N et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology aetiology and diagnosis. Eur Urol 65(2):389–398CrossRefPubMedGoogle Scholar
  19. Pannek J (2011) Treatment of Urinary Tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. A questionnaire based survey and review of the literature. Journal of Spinal Cord Medicine, 34(1):11–15Google Scholar
  20. Patil NJ, Nagaratna R, Garner C, Raghurman NV (2012) Effect of integrated yoga on neurogenic bladder dysfunction in patients with multiple sclerosis–a prospective observational series. Compliment Ther Med 20:424–430CrossRefGoogle Scholar
  21. Prieto J, Murphy CL, Moore KN, Fader M (2014) Catheterisation for long term bladder management (Review). Cochran Libr 9:1–97Google Scholar
  22. Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, Pannek J, Piotr R, Wyandaele J (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56:81–88CrossRefPubMedGoogle Scholar
  23. Tubaro A, Puccini F, De Nunzio C, Diggesu GA, Elneil S, Gobbi C, Khullar V (2012) The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systemic review. Curr Urol Rep 13:335–342CrossRefPubMedGoogle Scholar
  24. Valente S, Du Beau C, Chancellor D et al (2014) Epidemiology and demographics of the underactive bladder: a cross sectional survey. Int Urol Nephrol 46 (Suppl):S7–S10Google Scholar
  25. Weld K, Dmochowski R (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163:768–772CrossRefPubMedGoogle Scholar
  26. Yoshimura N, Chancellor MB (2011) Physiology and pharmacology of the bladder and urethra. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbells Urology, 10th edn. Elsevier, Philadelphia PA, USAGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Departments of Urology and Infectious DiseaseBeaumont HealthRoyal OakUSA

Personalised recommendations